Avantor, Inc. (NYSE:AVTR – Get Free Report) has received a consensus rating of “Moderate Buy” from the fifteen ratings firms that are covering the company, MarketBeat.com reports. Three research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year is $28.00.
AVTR has been the subject of several recent research reports. Evercore ISI decreased their target price on shares of Avantor from $28.00 to $27.00 and set an “outperform” rating for the company in a research report on Tuesday, July 2nd. TD Cowen upped their price objective on shares of Avantor from $28.00 to $31.00 and gave the stock a “buy” rating in a report on Monday, July 29th. Royal Bank of Canada restated an “outperform” rating and set a $34.00 target price on shares of Avantor in a report on Thursday, September 26th. Stifel Nicolaus upped their price target on Avantor from $27.00 to $28.00 and gave the stock a “buy” rating in a research note on Monday, July 29th. Finally, UBS Group cut their price objective on Avantor from $30.00 to $29.00 and set a “buy” rating on the stock in a research note on Tuesday, October 8th.
View Our Latest Stock Analysis on AVTR
Insider Transactions at Avantor
Hedge Funds Weigh In On Avantor
Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Boston Partners grew its holdings in shares of Avantor by 2.2% during the 1st quarter. Boston Partners now owns 28,561,802 shares of the company’s stock worth $729,298,000 after purchasing an additional 624,369 shares in the last quarter. Canada Pension Plan Investment Board boosted its stake in Avantor by 6.8% during the second quarter. Canada Pension Plan Investment Board now owns 22,927,325 shares of the company’s stock worth $486,059,000 after buying an additional 1,463,695 shares in the last quarter. Artemis Investment Management LLP increased its holdings in Avantor by 14.9% in the 1st quarter. Artemis Investment Management LLP now owns 9,120,083 shares of the company’s stock valued at $233,109,000 after buying an additional 1,180,937 shares during the period. 1832 Asset Management L.P. raised its stake in shares of Avantor by 1,634.9% in the 2nd quarter. 1832 Asset Management L.P. now owns 8,530,118 shares of the company’s stock valued at $180,839,000 after buying an additional 8,038,451 shares in the last quarter. Finally, Bessemer Group Inc. lifted its holdings in shares of Avantor by 4.4% during the 1st quarter. Bessemer Group Inc. now owns 7,099,848 shares of the company’s stock worth $181,544,000 after acquiring an additional 297,534 shares during the period. 95.08% of the stock is currently owned by institutional investors.
Avantor Price Performance
Shares of NYSE:AVTR opened at $24.79 on Friday. The firm has a market cap of $16.84 billion, a price-to-earnings ratio of 63.56, a P/E/G ratio of 2.93 and a beta of 1.33. Avantor has a 1 year low of $16.63 and a 1 year high of $28.00. The company has a current ratio of 1.59, a quick ratio of 1.05 and a debt-to-equity ratio of 0.89. The business has a fifty day simple moving average of $25.66 and a 200 day simple moving average of $24.34.
Avantor (NYSE:AVTR – Get Free Report) last announced its quarterly earnings results on Friday, July 26th. The company reported $0.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.23 by $0.02. The business had revenue of $1.70 billion during the quarter, compared to analyst estimates of $1.70 billion. Avantor had a return on equity of 12.40% and a net margin of 5.28%. As a group, sell-side analysts predict that Avantor will post 1.01 earnings per share for the current fiscal year.
About Avantor
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
Featured Stories
- Five stocks we like better than Avantor
- Following Congress Stock Trades
- Taiwan Semiconductor Stock: Buy Now or Wait for Earnings?
- 5 Top Rated Dividend Stocks to Consider
- Abbott’s Growth and Dividends Make It a Smart Portfolio Pick
- Compound Interest and Why It Matters When Investing
- Citigroup Faces Growing Troubles: Could the Industry Be at Risk?
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.